Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Debt Ratio (2016 - 2025)

Altimmune (ALT) has disclosed Debt Ratio for 13 consecutive years, with 0.07 as the latest value for Q3 2025.

  • On a quarterly basis, Debt Ratio changed N/A to 0.07 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.07, a N/A change, with the full-year FY2022 number at 0.02, down 35.77% from a year prior.
  • Debt Ratio was 0.07 for Q3 2025 at Altimmune, down from 0.08 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.08 in Q2 2025 to a low of 0.01 in Q2 2021.
  • A 4-year average of 0.03 and a median of 0.02 in 2023 define the central range for Debt Ratio.
  • Biggest YoY gain for Debt Ratio was 362.08% in 2021; the steepest drop was 80.3% in 2021.
  • Altimmune's Debt Ratio stood at 0.03 in 2021, then tumbled by 35.77% to 0.02 in 2022, then increased by 16.74% to 0.03 in 2023, then skyrocketed by 155.86% to 0.07 in 2025.
  • Per Business Quant, the three most recent readings for ALT's Debt Ratio are 0.07 (Q3 2025), 0.08 (Q2 2025), and 0.03 (Q3 2023).